05:07 AM EST, 02/25/2025 (MT Newswires) -- Myriad Genetics ( MYGN ) said late Monday it has named Chief Operating Officer Sam Raha as chief executive and president, effective April 30, succeeding Paul Diaz.

Diaz, who is leaving to become a managing partner at private-equity firm Cressey, will continue serving as consultant to Raha.

Myriad said that Chief Commercial Officer Mark Verratti will be promoted to COO and that it will hire a new chief commercial officer.